PharmaShots | Incisive News in 3 Shots

Subscribe Now

Vasa Therapeutics

Vasa Therapeutics Reports the Initiation of the P-I Trial Evaluating VS-041 for the Treatment of HFpEF

Vasa Therapeutics Reports the Initiation of the P-I Trial Evaluating VS-041 for the Treatment of HFpEF

September 4, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us